DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,600,000 | +72.2% | 26,013 | +34.8% | 0.54% | +54.0% |
| Q1 2020 | $2,672,000 | +368.0% | 19,303 | +418.8% | 0.35% | +486.7% |
| Q4 2019 | $571,000 | +6.1% | 3,721 | -0.2% | 0.06% | -3.2% |
| Q3 2019 | $538,000 | -9.3% | 3,727 | -10.2% | 0.06% | -4.6% |
| Q2 2019 | $593,000 | +15.6% | 4,149 | +6.8% | 0.06% | +8.3% |
| Q1 2019 | $513,000 | +17.1% | 3,886 | -8.4% | 0.06% | +5.3% |
| Q4 2018 | $438,000 | -4.4% | 4,244 | +0.6% | 0.06% | 0.0% |
| Q3 2018 | $458,000 | +15.9% | 4,217 | +5.5% | 0.06% | -16.2% |
| Q2 2018 | $395,000 | -2.9% | 3,999 | -4.1% | 0.07% | +6.2% |
| Q4 2017 | $407,000 | +6.8% | 4,171 | -5.2% | 0.06% | +1.6% |
| Q3 2017 | $381,000 | +54.9% | 4,402 | +40.4% | 0.06% | -40.0% |
| Q3 2016 | $246,000 | -6.5% | 3,136 | +20.5% | 0.10% | -9.5% |
| Q2 2016 | $263,000 | +3.5% | 2,603 | -2.9% | 0.12% | -3.3% |
| Q1 2016 | $254,000 | -3.1% | 2,682 | -4.8% | 0.12% | +1.7% |
| Q4 2015 | $262,000 | +11.0% | 2,817 | +1.7% | 0.12% | -2.5% |
| Q3 2015 | $236,000 | -24.1% | 2,771 | -23.7% | 0.12% | -12.9% |
| Q2 2015 | $311,000 | +9.1% | 3,633 | +8.3% | 0.14% | +8.6% |
| Q1 2015 | $285,000 | +18.3% | 3,355 | +19.3% | 0.13% | -3.0% |
| Q4 2014 | $241,000 | +17.6% | 2,812 | +7.7% | 0.13% | +15.8% |
| Q2 2014 | $205,000 | – | 2,610 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |